22 May 2013
Keywords: kosan, gets, epothilone, rights, back, roche, swiss
Article | 05 November 2007
Swiss drug major Roche and US firm Kosan Bioscience are concluding their epothilone development and commercialization collaboration. The
agreement entered ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 November 2007
21 May 2013
© 2013 thepharmaletter.com